Frontier Capital Management CO LLC Adc Therapeutics Sa Transaction History

Frontier Capital Management CO LLC

  • $9.96 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 09, 2021
SELL
$20.38 - $27.04 $1.59 Million - $2.11 Million
-78,137 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$22.75 - $34.05 $3.98 Million - $5.95 Million
-174,745 Reduced 69.1%
78,137 $1.91 Million
Q4 2020

Jan 19, 2021
BUY
$25.26 - $38.02 $1.58 Million - $2.37 Million
62,461 Added 32.8%
252,882 $8.1 Million
Q3 2020

Nov 16, 2020
BUY
$32.87 - $51.05 $6.26 Million - $9.72 Million
190,421 New
190,421 $6.28 Million

Others Institutions Holding ADCT

# of Institutions
79
Shares Held
55M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $155M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email